European multicentre study to define disease activity criteria for systemic sclerosis.: II.: Identification of disease activity variables and development of preliminary activity indexes
European multicentre study to define disease activity criteria for systemic sclerosis.: II.: Identification of disease activity variables and development of preliminary activity indexes
复制标题
DOI:
10.1136/ard.60.6.592
复制
发表时间:
2001-06-01
影响因子:
27.4
通讯作者:
Vlachoyiannopoulos, PJ
中科院分区:
文献类型:
--
作者:
Valentini, G;Della Rossa, A;Vlachoyiannopoulos, PJ
Objective-To develop criteria for disease activity in systemic sclerosis (SSc) that are valid, reliable, and easy to use.Methods-Investigators from 19 European centres completed a standardised clinical chart for a consecutive number of patients with SSc. Three protocol management members blindly evaluated each chart and assigned a disease activity score on a semiquantitative scale of 0-10. Two of them, in addition, gave a blinded, qualitative evaluation of disease activity ("inactive to moderately active" or "active to very active" disease). Both these evaluations were found to be reliable. A final disease activity score and qualitative evaluation of disease activity were arrived at by consensus for each patient; the former represented the gold standard for subsequent analyses. The correlations between individual items in the chart and this gold standard were then analysed.Results-A total of 290 patients with SSc (117 with diffuse SSc (dSSc) and 173 with limited SSc (lSSc)) were enrolled in the study. The items (including Delta -factors-that is, worsening according to the patient report) that were found to correlate with the gold standard on multiple regression were used to construct three separate 10-point indices of disease activity: (a) Delta -cardiopulmonary (4.0), Delta -skin (3.0), Delta -vascular (2.0), and Delta -articular/muscular (1.0) for patients with dSSc; (b) Delta -skin (2.5), erythrocyte sedimentation rate (ESR) >30 mm/1st h (2.5), Delta -cardiopulmonary (1.5), Delta -vascular (1.0), arthritis (1.0), hypocomplementaemia (1.0), and scleredema (0.5) for lSSc; (c) Delta -cardiopulmonary (2.0), Delta -skin (2.0), ESR >30 mm/1st h (1.5), total skin score >20 (1.0), hypocomplementaemia (1.0), scleredema (0.5), digital necrosis (0.5), Delta -vascular (0.5), arthritis (0.5), TLCO